Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
60
TNDM Quote, Financials, Valuation and Earnings
Last price:
$35.21
Seasonality move
:
12.65%
Day range:
$32.46 - $36.31
52-week range:
$21.85 - $53.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.75x
P/B ratio:
9.94x
Volume:
4.2M
Avg. volume:
1.5M
1-year change:
30.53%
Market cap:
$2.4B
Revenue:
$747.7M
EPS (TTM):
-$1.93
Earnings Data
Next earnings date for TNDM
Feb 21
2025
Most recent earnings per share
-$0.35
Beat by $0.06
(Nov 6/2024)
Consensus Estimate
-$0.41
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TNDM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/21/2025 | Q4 | $251.4M | -- | -- | -$0.24 | -- |
| 11/06/2024 | Q3 | $224.1M | $244M | -$0.35 | -$0.41 | $0.06 |
| 08/01/2024 | Q2 | $205.9M | $221.9M | -$0.47 | -$0.53 | $0.06 |
| 05/02/2024 | Q1 | $173.5M | $191.7M | -$0.65 | -$0.76 | $0.11 |
| 02/21/2024 | Q4 | $202.8M | $196.8M | -$0.46 | -$0.26 | -$0.20 |
| 11/01/2023 | Q3 | -- | -- | -$0.51 | -$0.36 | -$0.15 |
| 08/03/2023 | Q2 | -- | -- | -$0.55 | -$0.49 | -$0.06 |
| 05/03/2023 | Q1 | -- | -- | -$1.92 | -$0.53 | -$1.39 |
| 02/22/2023 | Q4 | -- | -- | -$0.25 | -$0.08 | -$0.17 |
| 11/02/2022 | Q3 | -- | -- | -$0.76 | -$0.05 | -$0.71 |
| 08/03/2022 | Q2 | -- | -- | -$0.24 | $0.02 | -$0.26 |
| 05/04/2022 | Q1 | -- | -- | -$0.23 | -$0.07 | -$0.16 |
| 02/22/2022 | Q4 | -- | -- | $0.16 | $0.21 | -$0.05 |
| 11/03/2021 | Q3 | -- | -- | $0.09 | $0.06 | $0.03 |
| 08/04/2021 | Q2 | -- | -- | $0.06 | -$0.08 | $0.14 |
| 05/05/2021 | Q1 | -- | -- | -$0.08 | -$0.15 | $0.07 |
| 02/24/2021 | Q4 | -- | -- | $0.22 | $0.12 | $0.10 |
| 11/05/2020 | Q3 | -- | -- | -$0.15 | -$0.12 | -$0.03 |
| 07/30/2020 | Q2 | -- | -- | -$0.45 | -$0.25 | -$0.20 |
| 04/30/2020 | Q1 | -- | -- | -$0.25 | -$0.18 | -$0.07 |
| 02/24/2020 | Q4 | -- | -- | $0.04 | -$0.03 | $0.07 |
| 11/04/2019 | Q3 | -- | -- | -$0.09 | -$0.22 | $0.13 |
| 08/01/2019 | Q2 | -- | -- | -$0.03 | -$0.29 | $0.26 |
| 04/30/2019 | Q1 | -- | -- | -$0.40 | -$0.29 | -$0.11 |
| 02/26/2019 | Q4 | -- | -- | $0.02 | -$0.20 | $0.22 |
| 11/01/2018 | Q3 | -- | -- | -$0.62 | -- | -- |
| 07/30/2018 | Q2 | -- | -- | -$1.17 | -- | -- |
| 04/26/2018 | Q1 | -- | -- | -$1.82 | -- | -- |
| 03/01/2018 | Q4 | -- | -- | -$1.23 | -- | -- |
| 10/26/2017 | Q3 | -- | -- | -$3.09 | -- | -- |
| 07/27/2017 | Q2 | -- | -- | -$4.36 | -- | -- |
| 04/27/2017 | Q1 | -- | -- | -$7.46 | -- | -- |
| 03/08/2017 | Q4 | -- | -- | -$4.80 | -- | -- |
| 11/01/2016 | Q3 | -- | -- | -$9.73 | -- | -- |
| 07/28/2016 | Q2 | -- | -- | -$6.00 | -- | -- |
| 04/28/2016 | Q1 | -- | -- | -$6.80 | -- | -- |
| 02/24/2016 | Q4 | -- | -- | -$4.00 | -- | -- |
| 10/29/2015 | Q3 | -- | -- | -$6.50 | -- | -- |
| 07/30/2015 | Q2 | -- | -- | -$6.50 | -- | -- |
| 04/30/2015 | Q1 | -- | -- | -$8.30 | -- | -- |
| 02/24/2015 | Q4 | -- | -- | -$7.80 | -- | -- |
Tandem Diabetes Care Earnings Questions
-
How Much did Tandem Diabetes Care Generate in Revenue Last Quarter?
Tandem Diabetes Care reported $244M worth of top line sales in its most recent quarter.
-
Did Tandem Diabetes Care Beat Earnings Last Quarter?
Tandem Diabetes Care announced earnings per share of -$0.35 which represents a beat of analyst forecast a -$0.41 per share.
-
Is Tandem Diabetes Care Profitable?
Tandem Diabetes Care reported $124.7M that represents $1.90 per share over the last quarter.
-
What is the Analyst Consensus for Tandem Diabetes Care EPS Next Year?
Tandem Diabetes Care's earnings are forecast to decrease from -$3.43 per share to -$1.82 per share next year representing a decrease of -49.89%.
-
When is Tandem Diabetes Care's Earnings Date?
Tandem Diabetes Care's next earnings date is February 21, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 5.45% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 8.95% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 3.34% over the past day.
